AstraZeneca Reports Lynparza Success in Breast Cancer Trials


AstraZeneca plc said Monday that one of its new drugs has proven more effective than chemotherapy in treating a certain type of breast cancer. The Anglo-Swedish firm said Lynparza showed a statistically significant and clinically meaningful improvement in progression-free survival, when compares with a physician's choice of standard chemotherapy, during its phase III OlympiAD trial.



from Biotech News